Patents by Inventor Valentin A. Pavlov

Valentin A. Pavlov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STIMULATION OF THE CELIAC-SUPERIOR MESENTERIC GANGLION COMPLEX FOR TREATING INFLAMMATION
    Publication number: 20250144449
    Abstract: Methods are disclosed for treating inflammatory disease states in a mammalian patient (e.g., human) by applying noninvasive focused ultrasound stimulation to the celiac-superior mesenteric ganglion complex of the patient.
    Type: Application
    Filed: October 29, 2024
    Publication date: May 8, 2025
    Applicant: The Feinstein Institutes for Medical Research
    Inventors: Valentin A. Pavlov, Santhoshi Poonacha Palandira, Kevin J. Tracey
  • TREATMENT OF INFLAMMATION BY SELECTIVE DMV CHOLINERGIC NEURON STIMULATION
    Publication number: 20240100336
    Abstract: Methods for electrical modulation of inflammation or serum TNF levels in a subject.
    Type: Application
    Filed: September 27, 2023
    Publication date: March 28, 2024
    Inventors: Adam M. Kressel, Valentin A. Pavlov, Sangeeta S. Chavan, Kevin J. Tracey
  • Treatment of inflammation by selective DMV cholinergic neuron stimulation
    Patent number: 11794013
    Abstract: Methods for electrical modulation of inflammation or serum TNF levels in a subject.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: October 24, 2023
    Assignee: The Feinstein Institutes for Medical Research
    Inventors: Adam M. Kressel, Valentin A. Pavlov, Sangeeta S. Chavan, Kevin J. Tracey
  • TREATMENT OF INFLAMMATION BY SELECTIVE DMV CHOLINERGIC NEURON STIMULATION
    Publication number: 20210196955
    Abstract: Methods for electrical modulation of inflammation or serum TNF levels in a subject.
    Type: Application
    Filed: February 24, 2021
    Publication date: July 1, 2021
    Inventors: Adam M. Kressel, Valentin A. Pavlov, Sangeeta S. Chavan, Kevin J. Tracey
  • Treatment of inflammation by selective DMV cholinergic neuron stimulation
    Patent number: 10933240
    Abstract: Methods for electrical modulation of inflammation or serum TNF levels in a subject.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: March 2, 2021
    Assignee: The Feinstein Institutes for Medical Research
    Inventors: Adam M. Kressel, Valentin A. Pavlov, Sangeeta S. Chavan, Kevin J. Tracey
  • TREATMENT OF INFLAMMATION BY SELECTIVE DMV CHOLINERGIC NEURON STIMULATION
    Publication number: 20190247659
    Abstract: Methods for electrical modulation of inflammation or serum TNF levels in a subject.
    Type: Application
    Filed: February 11, 2019
    Publication date: August 15, 2019
    Applicant: THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
    Inventors: Adam M. Kressel, Valentin A. Pavlov, Sangeeta S. Chavan, Kevin J. Tracey
  • Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
    Patent number: 8865641
    Abstract: A method of treating a fatty liver disease in a subject. The method comprises administering to the subject an effective amount of a cholinergic pathway stimulating agent, wherein the fatty liver disease is selected from non-alcoholic fatty liver (NAFL), alcoholic fatty liver (AFL), non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), NASH-associated liver fibrosis, ASH-associated liver fibrosis, non-alcoholic cirrhosis, and alcoholic cirrhosis.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: October 21, 2014
    Assignee: The Feinstein Institute for Medical Research
    Inventors: Valentin A. Pavlov, Kevin J. Tracey
  • METHODS OF TREATMENT OF FATTY LIVER DISEASE BY PHARMACOLOGICAL ACTIVATION OF CHOLINERGIC PATHWAYS
    Publication number: 20120322719
    Abstract: A method of treating a fatty liver disease in a subject. The method comprises administering to the subject an effective amount of a cholinergic pathway stimulating agent, wherein the fatty liver disease is selected from non-alcoholic fatty liver (NAFL), alcoholic fatty liver (AFL), non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), NASH-associated liver fibrosis, ASH-associated liver fibrosis, non-alcoholic cirrhosis, and alcoholic cirrhosis.
    Type: Application
    Filed: June 14, 2012
    Publication date: December 20, 2012
    Applicant: The Feinstein Institute For Medical Research
    Inventors: Valentin A. Pavlov, Kevin J. Tracey
  • Cholinesterase Inhibitors for Treating Inflammation
    Publication number: 20110293640
    Abstract: A method of treating a subject with a cytokine-mediated inflammatory disorder comprising administering to the subject an effective amount of a pharmaceutically acceptable cholinesterase inhibitor, provided that the inhibitor is not galantamine.
    Type: Application
    Filed: May 27, 2011
    Publication date: December 1, 2011
    Inventors: Kevin J. Tracey, Valentin A. Pavlov
  • Cholinesterase inhibitors for treating inflammation
    Patent number: 8003632
    Abstract: A method of treating a subject with a cytokine-mediated inflammatory disorder comprising administering to the subject an effective amount of a pharmaceutically acceptable cholinesterase inhibitor, provided that the inhibitor is not galantamine.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: August 23, 2011
    Assignee: The Feinstein Institute for Medical Research
    Inventors: Kevin J. Tracey, Valentin A. Pavlov